9. Bartus R. T., Hayward N. J., Elliott P. J., Sawyer S. D., Baker K. L., Dean R. L., Akiyama A., Straub J. A., Harbeson S. L. and
Li Z. (1994) Calpain inhibitor AK295 protects neurons from focal brain ischemia. Effects of postocclusion intra-arterial
administration. Stroke 25, 2265–2270.
10. Bi X., Tocco G. and Baudry M. (1994) Calpain-mediated regulation of AMPA receptors in adult rat brain. NeuroReport 6,
61–64.
11. Caner H., Collins J. L., Harris S. M., Kassell N. F. and Lee K. S. (1993) Attenuation of AMPA-induced neurotoxicity by a
calpain inhibitor. Brain Res. 607, 354–356.
12. Carden M. J., Trojanowski J. Q., Schlaepfer W. W. and Lee V. M. (1987) Two-stage expression of neurofilament polypeptides
during rat neurogenesis with early establishment of adult phosphorylation patterns. J. Neurosci. 7, 3489–3504.
13. Croall D. E. and DeMartino G. N. (1991) Calcium-activated neutral protease (calpain) system: structure, function, and
regulation. Physiol. Rev. 71, 813–847.
14. Fehlings M. G. and Agrawal S. (1995) Role of sodium in the pathophysiology of secondary spinal cord injury. Spine 20,
2187–2191.
15. Fehlings M. G. and Nashmi R. (1995) Assessment of axonal dysfunction in an in vitro model of acute compressive injury to
adult rat spinal cord axons. Brain Res. 677, 291–299.
16. Geisler N., Vandekerckhove J. and Weber K. (1987) Location and sequence characterization of the major phosphorylation sites
of the high molecular mass neurofilament proteins M and H. Fedn Eur. biochem. Socs Lett. 221, 403–407.
17. Goll D. E., Dayton W. R., Singh I. and Robson R. M. (1991) Studies of the alpha-actinin/actin interaction in the Z-disk by using
calpain. J. biol. Chem. 266, 8501–8510.
18. Greenwood J. A., Troncoso J. C., Costello A. C. and Johnson G. V. (1993) Phosphorylation modulates calpain-mediated
proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins. J. Neurochem. 61, 191–199.
19. Hamakubo T., Kannagi R., Murachi T. and Matus A. (1986) Distribution of calpains I and II in rat brain. J. Neurosci. 6,
3103–3111.
20. Happel R. D., Banik N. L., Balentine J. D. and Hogan E. L. (1984) Tissue calcium levels in CaCl2-induced myelopathy.
Neurosci. Lett. 49, 279–283.
21. Happel R. D., Smith K. P., Banik N. L., Powers J. M., Hogan E. L. and Balentine J. D. (1981) Ca2 + -accumulation in
experimental spinal cord trauma. Brain Res. 211, 476–479.
22. Hayes R. L., Yang K., Whitson J. S. and Postmantur R. (1995) Cytoskeletal derangements following central nervous system
injury: modulation by neurotrophic gene transfection. J. Neurotrauma 12, 933–941.
23. Hoffman P. N., Cleveland D. W., Griffin J. W., Landes P. W., Cowan N. J. and Price D. L. (1987) Neurofilament gene
expression: a major determinant of axonal caliber. Proc. natn. Acad. Sci. U.S.A. 84, 3472–3476.
24. Hoffman P. N., Thompson G. W., Griffin J. W. and Price D. L. (1985) Changes in neurofilament transport coincide temporally
with alterations in the caliber of axons in regenerating motor fibers. J. Cell Biol. 101, 1332–1340.
25. Kaku Y., Yonekawa Y., Tsukahara T., Ogata N., Kimura T. and Taniguchi T. (1993) Alterations of a 200 kDa neurofilament in
the rat hippocampus after forebrain ischemia. J. cerebr. Blood Flow Metab. 13, 402–408.
26. Kampfl A., Posmantur R., Nixon R., Grynspan F., Zhao X., Liu S. J., Newcomb J. K., Clifton G. L. and Hayes R. L. (1996)
mu-Calpain activation and calpain-mediated cytoskeletal proteolysis following traumatic brain injury. J. Neurochem. 67,
1575–1583.
27. Kishimoto A. (1990) Limited proteolysis of protein kinase C by calpain, its possible implication. Adv. Second Mess.
Phosphoprot. Res. 24, 472–477.
28. Li Z., Hogan E. L. and Banik N. L. (1995) Role of calpain in spinal cord injury: increased m-calpain immunoreactivity in spinal
cord after compression injury in the rat. Neurochem. Int. 27, 425–432.
29. Li Z., Hogan E. L. and Banik N. L. (1996) Role of calpain in spinal cord injury: increased calpain immunoreactivity in rat
spinal cord after impact trauma. Neurochem. Res. 21, 441–448.
30. Lynch G. and Baudry M. (1987) Brain spectrin, calpain and long-term changes in synaptic efficacy. Brain Res. Bull. 18,
809–815.
31. Melloni E. and Pontremoli S. (1989) The calpains. Trends Neurosci. 12, 438–444.
32. Nakamura M., Araki M., Oguro K. and Masuzawa T. (1992) Differential distribution of 68 Kd and 200 Kd neurofilament
proteins in the gerbil hippocampus and their early distributional changes following transient forebrain ischemia. Expl Brain
Res. 89, 31–39.
33. Nixon R. A. and Sihag R. K. (1991) Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci.
14, 501–506.
34. Pant H. C. (1988) Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain.
Biochem. J. 256, 665–668.
35. Perlmutter L. S., Siman R., Gall C., Seubert P., Baudry M. and Lynch G. (1988) The ultrastructural localization of calciumactivated protease “calpain” in rat brain.Synapse 2, 79–88.
36. Peterson G. L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Analyt.
Biochem. 83, 346–356.
37. Posmantur R., Hayes R. L., Dixon C. E. and Taft W. C. (1994) Neurofilament 68 and neurofilament 200 protein levels decrease
after traumatic brain injury. J. Neurotrauma 11, 533–545.
38. Posmantur R., Kampfl A., Siman R., Liu J., Zhao X., Clifton G. L. and Hayes R. L. (1997) A calpain inhibitor attenuates
cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat. Neuroscience 77, 875–888.
39. Rivlin A. S. and Tator C. H. (1979) Effect of vasodilators and myelotomy on recovery after acute spinal cord injury in rats.
J. Neurosurg. 50, 349–352.
40. Roberts-Lewis J. M., Savage M. J., Marcy V. R., Pinsker L. R. and Siman R. (1994) Immunolocalization of calpain I-mediated
spectrin degradation to vulnerable neurons in the ischemic gerbil brain. J. Neurosci. 14, 3934–3944.
41. Saatman K. E., Bozyczko-Coyne D., Marcy V., Siman R. and McIntosh T. K. (1996) Prolonged calpain-mediated
spectrin breakdown occurs regionally following experimental brain injury in the rat. J. Neuropath. exp. Neurol. 55,
850–860.
42. Saatman K. E., Murai H., Bartus R. T., Smith D. H., Hayward N. J., Perri B. R. and McIntosh T. K. (1996) Calpain inhibitor
AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc. natn. Acad. Sci. U.S.A. 93,
3428–3433.
43. Saido T. C., Sorimachi H. and Suzuki K. (1994) Calpain: new perspectives in molecular diversity and physiological-patho-
